279 Advances in New Modalities (Large Molecule, Oligos, Peptides, ADCs, Gene therapy, etc.) Product and Process Development

Friday, November 20, 2020: 8:00 AM - 9:00 AM
Pharmaceutical Discovery, Development and Manufacturing Forum (26) (PreRecorded+)

Description:
This session welcomes papers addressing the latest advances in the fundamental and applied studies of product and process development of both established and emerging novel pharmaceutical modalities. Examples include large molecule, oligos, peptides, ADCs, gene therapy and other now modalities in pharmaceuticals. Scientists and engineers involved in upstream and downstream development, processing, scale-up and transfer of these products are invited. Topics may include, but not limited to, cell culture preparation/fermentation, separation/purification, formulation/buffer exchange, fill/finish and finished device/delivery.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Chemical Engineers in Medicine (TF)
Chair:
Michael L. Hoffman Email: Michael.Hoffman@abbvie.com
Co-Chair:
XiaoXiang Zhu Email: xzhu01@amgen.com


(279b) High Throughput Process Development for CEX Chromatography
Nicholas Vecchiarello, Pranali Shah, Nitya Jacob and Glen Bolton



(279e) In-Situ Monitoring during Mixing for Protein Crystallisation
Frederik J. Link, Ian Rosbottom and Jerry Y. Y. Heng


(279f) The Use of Nanofiltration Systems in Synthetic Peptide Processes
Nil Tandogan, Nicholas Klitzing, Frank Torres Torres and Kevin D. Seibert